Thus, the activation of HIF-1α significantly influences the metabolic reprogramming of breast cancer cells by promoting glycolysis, enhancing survival under hypoxic conditions, supporting metastatic potential, and contributing to therapeutic resistance. Here, HIF1A is linked to breast cancer.